Comparison of sociodemographic and clinical characteristics of bipolar type 1 patients on single or double mood stabilizers treatment

Basit Öğe Kaydı
dc.contributor.authorYilmaz, Filiz Dere
dc.contributor.authorYavuz, Kaasim Fatih
dc.contributor.authorAltinbas, Kursat
dc.contributor.authorLordoglu, Dilek Yesilbas
dc.contributor.authorKurt, Erhan
dc.date.accessioned2025-01-27T19:02:27Z
dc.date.available2025-01-27T19:02:27Z
dc.date.issued2015
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractObjective: Purpose of the current study is to compare the demographic and clinical characteristics, prognoses and episode characteristics between patients on a single mood stabilizer treatment and those on double mood stabilizer treatment. Methods: The follow-up files of 167 patients who met DSM-IV-TR criteria for bipolar-I disorder were examined retrospectively. Patients were divided into two groups, with 136 patients on a single mood stabilizer and 31 patients on double mood stabilizer treatment. Sociodemographic and clinical characteristics of the groups were evaluated. The data derived from the study were analyzed with SPSS (Statistical Package for Social Sciences) for Windows 17.0. The data were evaluated with chi-square and t test. Results: The number of women was significantly higher in the single mood stabilizer group. The total number of episodes and hospitalizations were higher in patients on double mood stabilizer treatment compared to the single mood stabilizer group. When comparing within the single medication group, the total number of episodes and hospitalizations in patients using Lithium were significantly lower than in patients on valproat. Conclusion: Patients medicated with double mood stabilizer may be more difficult to treat and have a poorer prognosis than patients medicated with a single mood stabilizer. The number of female patients was greater in the single mood stabilizer group, which may indicate a generally more positive outcome in women. However, this research was cross-sectional and had a relatively low sample size, making it rather difficult to come to a more definite conclusion. Therefore, follow-up studies with a greater number of patients on a single mood stabilizer over an extended period of time are required.
dc.identifier.doi10.5350/DAJPN2015280407
dc.identifier.endpage361
dc.identifier.issn1018-8681
dc.identifier.issue4
dc.identifier.scopus2-s2.0-84953747973
dc.identifier.scopusqualityQ3
dc.identifier.startpage356
dc.identifier.urihttps://doi.org/10.5350/DAJPN2015280407
dc.identifier.urihttps://hdl.handle.net/20.500.12428/13502
dc.identifier.volume28
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherYerkure Tanitim ve Yayincilik
dc.relation.ispartofDusunen Adam - The Journal of Psychiatry and Neurological Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_Scopus_20250125
dc.subjectBipolar disorder; Clinical characteristics; Mood stabilizer
dc.titleComparison of sociodemographic and clinical characteristics of bipolar type 1 patients on single or double mood stabilizers treatment
dc.typeArticle

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu